{"id":"https://openalex.org/W2282058342","doi":"https://doi.org/10.1182/blood.v83.2.404.404","title":"Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences","display_name":"Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences","publication_year":1994,"publication_date":"1994-01-15","ids":{"openalex":"https://openalex.org/W2282058342","doi":"https://doi.org/10.1182/blood.v83.2.404.404","mag":"2282058342","pmid":"https://pubmed.ncbi.nlm.nih.gov/8286740"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v83.2.404.404","doi":"https://doi.org/10.1182/blood.v83.2.404.404","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v83.2.404.404","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042254050","display_name":"Boris Pasche","orcid":"https://orcid.org/0000-0002-3750-7898","observed_orcids":["https://orcid.org/0000-0002-3750-7898"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Pasche","raw_affiliation_strings":["Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070042070","display_name":"H\u00e9l\u00e8ne Ouimet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Ouimet","raw_affiliation_strings":["Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S Francis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Francis","raw_affiliation_strings":["Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028396638","display_name":"Joseph Loscalzo","orcid":"https://orcid.org/0000-0002-1153-8047","observed_orcids":["https://orcid.org/0000-0002-1153-8047"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Loscalzo","raw_affiliation_strings":["Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Divisions, Brigham and Women's Hospital, Boston, MA 02115","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1283280774"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.1923,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.79561936,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"83","issue":"2","first_page":"404","last_page":"414"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.02239999920129776,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasmin","display_name":"plasmin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/glycoprotein-iib-iiia","display_name":"integrin \u03b1IIb\u03b23","score":0.9459999799728394},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.7360000014305115},{"id":"https://openalex.org/keywords/fibrinogen-binding","display_name":"fibrinogen binding","score":0.9559999704360962},{"id":"https://openalex.org/keywords/proteolytic-cleavage","display_name":"proteolytic cleavage","score":0.6039999723434448},{"id":"https://openalex.org/keywords/fibrinogen-receptor","display_name":"fibrinogen receptor","score":0.6579999923706055},{"id":"https://openalex.org/keywords/platelet-rich-plasma","display_name":"platelet-rich plasma","score":0.7289999723434448},{"id":"https://openalex.org/keywords/platelet-structure","display_name":"platelet structure","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C2781071845","wikidata":"https://www.wikidata.org/wiki/Q21173374","display_name":"Plasmin","level":3,"score":0.9268732666969299},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.8247785568237305},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.707374095916748},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6950241923332214},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5477381348609924},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.4655049443244934},{"id":"https://openalex.org/C26828662","wikidata":"https://www.wikidata.org/wiki/Q7202248","display_name":"Platelet membrane glycoprotein","level":3,"score":0.43153926730155945},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3469538986682892},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18354129791259766},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17225244641304016},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.11196047067642212}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005338","descriptor_name":"Fibrin Fibrinogen Degradation Products","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005341","descriptor_name":"Fibrinolysin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015151","descriptor_name":"Immunoblotting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015539","descriptor_name":"Platelet Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1182/blood.v83.2.404.404","doi":"https://doi.org/10.1182/blood.v83.2.404.404","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v83.2.404.404","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v83.2.404.bloodjournal832404","doi":"https://doi.org/10.1182/blood.v83.2.404.bloodjournal832404","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v83.2.404.bloodjournal832404","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:8286740","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8286740","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.970.9284","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.970.9284","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bloodjournal.org/content/bloodjournal/83/2/404.full.pdf?sso-checked%3Dtrue","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7246000170707703}],"study_designs":[],"awards":[{"id":"https://openalex.org/G554591323","display_name":"PROTHROMBOTIC EFFECTS OF LIPOPROTEIN","funder_award_id":"R01HL043344","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6273422239","display_name":"PLATELETS, PLATELET AGGREGATES &PLASMINOGEN ACTIVATION","funder_award_id":"R01HL040411","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G8284249587","display_name":"Arterial Dysfunction: Basic and Clinical Mechanisms","funder_award_id":"P01HL048743","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W145795187","https://openalex.org/W266831738","https://openalex.org/W1489612807","https://openalex.org/W1501072984","https://openalex.org/W1517162073","https://openalex.org/W1520666812","https://openalex.org/W1530154863","https://openalex.org/W1555561206","https://openalex.org/W1556035179","https://openalex.org/W1567129527","https://openalex.org/W1932052686","https://openalex.org/W1976666984","https://openalex.org/W1982509240","https://openalex.org/W2004414131","https://openalex.org/W2008937610","https://openalex.org/W2009967151","https://openalex.org/W2012330153","https://openalex.org/W2027660297","https://openalex.org/W2031800865","https://openalex.org/W2056608541","https://openalex.org/W2057011331","https://openalex.org/W2070655273","https://openalex.org/W2076991332","https://openalex.org/W2078328099","https://openalex.org/W2100837269","https://openalex.org/W2122551066","https://openalex.org/W2148129851","https://openalex.org/W2170684533","https://openalex.org/W2342669116","https://openalex.org/W2402797734","https://openalex.org/W2410007954","https://openalex.org/W2887455519"],"related_works":["https://openalex.org/W7098352747","https://openalex.org/W2419473844","https://openalex.org/W2146689645","https://openalex.org/W163257244","https://openalex.org/W2006168471","https://openalex.org/W2090494902","https://openalex.org/W266831738","https://openalex.org/W2076646721","https://openalex.org/W145795187","https://openalex.org/W2056355602"],"abstract_inverted_index":{"Plasmin":[0,59],"exposure":[1],"modulates":[2],"platelet":[3,14,49],"aggregation":[4,183],"responses,":[5],"but":[6,102],"a":[7,26,67,78,140,160],"direct":[8],"effect":[9,44],"of":[10,45,57,85,111,138,149],"plasmin":[11,40,156],"on":[12,48,169],"the":[13,43,54,82,112,129,133,147],"fibrinogen":[15,51,64,170,180],"receptor,":[16],"glycoprotein":[17],"IIb/IIIa":[18],"(GPIIb/IIIa),":[19],"has":[20],"never":[21],"been":[22,98],"conclusively":[23],"shown":[24],"in":[25,36,66,73,81,132,146,164,179],"plasma":[27,38,150,165],"milieu.":[28],"To":[29],"examine":[30],"this":[31,46,71,103],"issue,":[32],"we":[33],"incubated":[34],"platelets":[35],"platelet-rich":[37],"with":[39,89,115],"and":[41,53,70,182],"measured":[42],"treatment":[47,60],"aggregation,":[50],"binding,":[52],"structural":[55],"integrity":[56],"GPIIb/IIIa.":[58],"reduced":[61],"maximal":[62,83],"reversible":[63],"binding":[65,74,171,181],"dose-dependent":[68],"fashion,":[69],"reduction":[72,80],"was":[75,105],"accompanied":[76,175],"by":[77,100,159,176],"correlative":[79],"rate":[84],"aggregation.":[86],"Immunoblots":[87],"performed":[88],"polyclonal":[90],"antibodies":[91],"against":[92],"GPIIb/IIIa":[93,114],"showed":[94,124],"that":[95,125,155,166],"GPIIIa":[96,139,158],"had":[97],"cleaved":[99],"plasmin,":[101],"cleavage":[104,126],"detected":[106],"only":[107,145],"after":[108],"subsequent":[109],"degradation":[110],"solubilized":[113],"Staphylococcus":[116],"aureus":[117],"V8":[118],"(Glu-C)":[119],"endoprotease.":[120],"Peptide":[121],"sequence":[122],"analysis":[123],"occurred":[127],"at":[128],"lys444-pro445":[130],"bond":[131],"first":[134],"cysteine-rich":[135],"repeat":[136],"domain":[137],"unique":[141,161],"proteolytic":[142,162],"event":[143,163],"observed":[144],"presence":[148],"fibrinogen.":[151],"These":[152],"observations":[153],"suggest":[154],"modifies":[157],"is":[167,174],"dependent":[168],"and,":[172],"consequently,":[173],"significant":[177],"reductions":[178],"response.":[184]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}